恩威医药(301331.SZ)：上半年净利润3834.42万元 同比增长113.80%

Core Insights - Enwei Pharmaceutical (301331.SZ) reported a revenue of 449 million yuan for the first half of 2025, representing a year-on-year growth of 15.73% [1] - The net profit attributable to shareholders reached 38.34 million yuan, showing a significant year-on-year increase of 113.80% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 35.28 million yuan, reflecting a year-on-year growth of 132.47% [1] - The basic earnings per share stood at 0.3845 yuan [1]